22 Jul Skylark Bio

Posted at 20:34h in by Brittany Miller

Jodi Cook, Ph.D., CEO and President

Oct. 7 | 11:00am | FLW Ballroom G

Cambridge, MA

(Private)

Skylark Bio is a gene therapy company working on targeted local delivery of gene therapies, initially focused on addressing pediatric genetic hearing loss, but with the potential to rapidly progress into other diseases. Genetic hearing loss is a devastating disorder that is diagnosed at birth and can impede speech and language development and subsequent learning, that can have life-long consequences. Through innovative gene therapy solutions, Skylark has a mission to create a world where anyone, anywhere can experience life in all its sensory dimensions.

skylarkbio.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions